Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (71)	9/13/1999 4:15:00 PM
From: LLCF	Respond to of 438

< SNAP.> Owned quite a bit based on the 'value' sheet [plus science of course] but luckily that rally took me out of quite a bit. Didn't buy back today... too 'wimpy'... have to reasses and see what they've got left!!!!!!! They've had so many meals returned I've got to see what's left on the menue! With INCY, SNAP, & GLIA, I'm down for that day, but not that much... hard to believe this stuff :) DAK

To: scaram(o)uche who wrote (71)	9/13/1999 5:11:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 438

There are in my opinion at least 2 reasons for today's advance. The announcement late last week of the breast cancer trials got no PR. However, I am told it got a splash in some Boston papers today. Also, a Yahoo poster claims that the Folkman research will appear in this Friday's "Science". This advance also means that they can raise capital with their $30 million equity line of credit with GENZ (issue stock for cash) a lot more cheaply now, a big plus in itself. I am still interested if in your opinion starting with the breast cancer trials with a similar/same technology as the cancer vaccine strategy on melanoma implicitly is a positive comment about the efficacy and results of that treatment in current trials. (It would seem to me that if the melanoma project did not show strong promise they would not proceed trying it on another disease?) The melanoma stuff is much further along than anything else and much more important to the short term results of the company. Also, I know nothing about these journals. Is SCIENCE a logical and respected place to publish results on the Folkman research?